Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DOK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PI4KAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6884 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL4R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VMA21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGFBP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR664B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGTRAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QDPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on